Literature DB >> 34160354

Familial Mediterranean Fever Mutation Analysis in Pediatric Patients With İnflammatory Bowel Disease: A Multicenter Study.

Nafiye Urgancı1, Funda Ozgenc2, Zarife Kuloğlu3, Hasan Yüksekkaya4, Sinan Sarı5, Tülay Erkan6, Zerrin Önal7, Gönül Çaltepe8, Mustafa Akçam9, Duran Arslan10, Nur Arslan11, Reha Artan12, Ayşen Aydoğan13, Necati Balamtekin14, Maşallah Baran15, Gökhan Baysoy16, Murat Çakır17, Buket Dalgıç5, Yaşar Doğan18, Özlem Durmaz19, Çiğdem Ecevıt20, Makbule Eren21, Selim Gökçe22, Fulya Gülerman23, Figen Gürakan24, Samil Hızlı25, Ishak Işık26, Ayhan Gazi Kalaycı8, Aydan Kansu3, Tufan Kutlu6, Hamza Karabiber27, Erhun Kasırga28, Günsel Kutluk7, Ferdağ Özbay Hoşnut29, Hasan Özen30, Tanju Özkan31, Yeşim Öztürk11, Özlem Bekem Soylu20, Engin Tutar32, Gökhan Tümgör33, Fatih Ünal34, Meltem Ugraş35, Gonca Üstündağ36, Aytaç Yaman37, Turkish Ibd Study Group38.   

Abstract

BACKGROUND: The aim of the study was to evaluate familial Mediterranean fever (FMF) mutation analysis in pediatric patients with inflammatory bowel disease (IBD). The relation between MEFV mutations and chronic inflammatory diseases has been reported previously.
METHODS: Children with IBD (334 ulcerative colitis (UC), 224 Crohn's disease (CD), 39 indeterminate colitis (IC)) were tested for FMF mutations in this multicenter study. The distribution of mutations according to disease type, histopathological findings, and disease activity indexes was determined.
RESULTS: A total of 597 children (mean age: 10.8 ± 4.6 years, M/F: 1.05) with IBD were included in the study. In this study, 41.9% of the patients had FMF mutations. E148Q was the most common mutation in UC and CD, and M694V in IC (30.5%, 34.5%, 47.1%, respectively). There was a significant difference in terms of endoscopic and histopathological findings according to mutation types (homozygous/ heterozygous) in patients with UC (P < .05). There was a statistically significant difference between colonoscopy findings in patients with or without mutations (P = .031, P = .045, respectively). The patients with UC who had mutations had lower Pediatric Ulcerative Colitis Activity Index (PUCAI) scores than the patients without mutations (P = .007).
CONCLUSION: Although FMF mutations are unrelated to CD patients, but observed in UC patients with low PUCAI scores, it was established that mutations do not have a high impact on inflammatory response and clinical outcome of the disease.

Entities:  

Mesh:

Year:  2021        PMID: 34160354      PMCID: PMC8975365          DOI: 10.5152/tjg.2021.20057

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  26 in total

1.  Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience.

Authors:  Jeffrey Hyams; James Markowitz; Anthony Otley; Joel Rosh; David Mack; Athos Bousvaros; Subra Kugathasan; M Pfefferkorn; Vasundhara Tolia; Jonathan Evans; William Treem; Robert Wyllie; Robert Rothbaum; J del Rosario; Aubrey Katz; Adam Mezoff; M Oliva-Hemker; Trudy Lerer; Anne Griffiths
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-10       Impact factor: 2.839

2.  The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever.

Authors:  Sabri Güncan; N Şule Y Bilge; Döndü Üsküdar Cansu; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Eur J Rheumatol       Date:  2016-09-01

3.  Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever.

Authors:  D Cattan; C Notarnicola; N Molinari; I Touitou
Journal:  Lancet       Date:  2000-01-29       Impact factor: 79.321

4.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

5.  The association of inflammatory bowel disease and Mediterranean fever gene (MEFV) mutations in Turkish children.

Authors:  Nuray Uslu; Aysel Yüce; Hülya Demir; Inci N Saltik-Temizel; Yusuf Usta; Engin Yilmaz; Nesrin Beşbaş; Figen Gürakan; Hasan Ozen; Seza Ozen
Journal:  Dig Dis Sci       Date:  2010-03-21       Impact factor: 3.199

6.  Familial Mediterranean fever gene (MEFV) mutations and disease severity in systemic lupus erythematosus (SLE): implications for the role of the E148Q MEFV allele in inflammation.

Authors:  R Deniz; G Ozen; S Yilmaz-Oner; F Alibaz-Oner; C Erzik; S Z Aydin; N Inanc; F Eren; F Bayalan; H Direskeneli; P Atagunduz
Journal:  Lupus       Date:  2014-11-20       Impact factor: 2.911

7.  Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study.

Authors:  Mehmet Tunca; Servet Akar; Fatos Onen; Huri Ozdogan; Ozgur Kasapcopur; Fatos Yalcinkaya; Ercan Tutar; Seza Ozen; Rezan Topaloglu; Engin Yilmaz; Mustafa Arici; Aysin Bakkaloglu; Nesrin Besbas; Tekin Akpolat; Ayhan Dinc; Eren Erken
Journal:  Medicine (Baltimore)       Date:  2005-01       Impact factor: 1.889

8.  MEFV gene mutations in Turkish children with juvenile idiopathic arthritis.

Authors:  Elif Comak; Cagla Serpil Dogan; Sema Akman; Mustafa Koyun; Arife Uslu Gokceoglu; Ibrahim Keser
Journal:  Eur J Pediatr       Date:  2013-04-16       Impact factor: 3.183

9.  The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy.

Authors:  Sinan Sari; Odul Egritas; Buket Dalgic
Journal:  Eur J Pediatr       Date:  2007-05-23       Impact factor: 3.183

10.  Detection of MEFV gene mutations in patients with inflammatory bowel disease.

Authors:  Erkan Yurtcu; Hale Gokcan; Ugur Yilmaz; Feride Iffet Sahin
Journal:  Genet Test Mol Biomarkers       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.